$PTCT
-
Markets
PTC Therapeutics Strikes a $2.9 Billion Licensing Agreement with Novartis
$PTCT In a significant move within the biopharmaceutical sector, PTC Therapeutics (NASDAQ: PTCT) has entered into a licensing agreement with…
Read More »